Unanticipated myocarditis in a surgical patient treated with pembrolizumab: A case report Journal Article


Authors: Nierstedt, R. T.; Yeahia, R.; Barnett, K. M.
Article Title: Unanticipated myocarditis in a surgical patient treated with pembrolizumab: A case report
Abstract: We report a case of fatal immune checkpoint inhibitor (ICI)-associated myocarditis in a 77-year-old man with metastatic non-small cell lung cancer (NSCLC) who presented for mediport placement at our outpatient surgical center. He denied any cardiac complaints and had a previously normal electrocardiogram (EKG) off treatment. Intraoperatively and postoperatively, he displayed cardiac rhythm abnormalities. The patient was then transferred to a tertiary facility, where he expired within 48 hours. As cancer immunotherapy becomes increasingly prominent, ICI-associated myocarditis should be considered a potentially critical contributor to perioperative cardiac morbidity and mortality.
Keywords: immunotherapy; receptor; immune
Journal Title: A and A Practice
Volume: 14
Issue: 6
ISSN: 2575-3126
Publisher: Lippincott Williams & Wilkins  
Date Published: 2020-04-01
Start Page: e01177
Language: English
ACCESSION: WOS:000531378700006
DOI: 10.1213/xaa.0000000000001177
PROVIDER: wos
PMCID: PMC7101019
PUBMED: 32132361
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rubaya   Yeahia
    5 Yeahia
  2. Kara Michelle Barnett
    14 Barnett